In accordance with the requirements of the Standards for Commercial Support of the Accreditation Council for Continuing  Medical Education, each instructor and member of the planning committee has been asked to   disclose any relevant financial relationships with commercial interests (defined as: any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients).  The information disclosed for this activity is listed below.

In addition, the planners and instructors listed have agreed that all recommendations involving clinical medicine  will be based on evidence that is generally accepted within the profession as adequate justification for their indications and contraindications in the care of patients; that all scientific research used in support or justification  of a patient care recommendation will conform to the generally accepted standards of experimental design, data  collection and analysis; and that material to be presented will be made available for advance peer review if requested.

Moderator:
Amy Prentice, Manager, State Government Relations, National Psoriasis Foundation, has no information to disclose.

Presenters:

Ashley C. Kenneth, Senior Manager of Advocacy, National Multiple Sclerosis Society, has no information to disclose.

Wassim Saikali, MD, has disclosed the following conflicts of interest:  Speaker: Celgene for which he has received an honorarium; Speaker/Clinical Trials: Pfizer, for which he has received an honorarium/PI; Clinical Trials: Johnson and Johnson for which he received PI.